Huber Capital Management LLC bought a new position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 28,670 shares of the medical instruments supplier's stock, valued at approximately $1,762,000. Huber Capital Management LLC owned about 0.85% of Utah Medical Products at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the stock. Golden State Wealth Management LLC bought a new stake in shares of Utah Medical Products in the fourth quarter worth $31,000. R Squared Ltd bought a new stake in shares of Utah Medical Products during the 4th quarter valued at about $49,000. BNP Paribas Financial Markets increased its position in shares of Utah Medical Products by 102.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock valued at $75,000 after purchasing an additional 566 shares during the last quarter. New Age Alpha Advisors LLC bought a new position in shares of Utah Medical Products in the 4th quarter worth approximately $101,000. Finally, SG Americas Securities LLC purchased a new position in shares of Utah Medical Products in the fourth quarter worth approximately $157,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.
Utah Medical Products Trading Down 0.9 %
UTMD stock traded down $0.50 during midday trading on Tuesday, reaching $53.89. 8,741 shares of the company's stock traded hands, compared to its average volume of 20,840. The stock's 50-day moving average is $58.81 and its 200 day moving average is $62.30. The stock has a market cap of $176.87 million, a P/E ratio of 13.64 and a beta of 0.17. Utah Medical Products, Inc. has a 52-week low of $53.40 and a 52-week high of $77.33.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.
Utah Medical Products Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th were given a dividend of $0.305 per share. The ex-dividend date was Friday, March 14th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.26%. Utah Medical Products's payout ratio is currently 30.89%.
About Utah Medical Products
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
